{"product_id":"the-royal-marsden-manual-of-cancer-nursing-procedures-isbn-9781119245186","title":"The Royal Marsden Manual of Cancer Nursing Procedures","description":"\u003cp\u003eThe Royal Marsden is the world’s first hospital dedicated to cancer diagnosis, treatment, research and education – a centre of excellence with an international reputation for ground-breaking research and pioneering the very latest in cancer treatments and technologies, as well as specialising in cancer diagnosis and education.  \u003c\/p\u003e \u003cp\u003eThis companion volume to the internationally successful \u003ci\u003eThe Royal Marsden Manual of Clinical Nursing Procedures\u003c\/i\u003e is designed to support practitioners who work specifically with oncology patients by providing detailed evidence-based procedures and rationale, and problem-solving guidance on all aspects of oncology nursing.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eThe Royal Marsden Manual of Cancer Nursing Procedures\u003c\/i\u003e:\u003c\/p\u003e \u003cul\u003e \u003cli\u003eIs organized and structured to represent the needs of the patient along their care pathway\u003c\/li\u003e \u003cli\u003eProvides the latest evidence underpinning all procedures\u003c\/li\u003e \u003cli\u003eIncludes information on haematological procedures; pain assessment and management; wound care; oncological emergencies; and end-of-life care\u003c\/li\u003e \u003cli\u003eGives detailed guidelines on supporting patients living with cancer with practical information on such things as benefits, exercise and nutrition.\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003e\u003ci\u003eThe Royal Marsden Manual of Cancer Nursing Procedures\u003c\/i\u003e is an invaluable, definitive resource for all those involved in the provision of cancer care and support to patients and their families.\u003c\/p\u003e \u003cp\u003eForeword xi\u003c\/p\u003e \u003cp\u003eAcknowledgements xii\u003c\/p\u003e \u003cp\u003eList of contributors xiii\u003c\/p\u003e \u003cp\u003eList of abbreviations xv\u003c\/p\u003e \u003cp\u003eQuick reference to the procedure guidelines xvii\u003c\/p\u003e \u003cp\u003eHow to use your manual xix\u003c\/p\u003e \u003cp\u003eIntroduction xxi\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Diagnostic investigations 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eOverview 2\u003c\/p\u003e \u003cp\u003eDiagnostic tests and investigations 2\u003c\/p\u003e \u003cp\u003eTumour markers 4\u003c\/p\u003e \u003cp\u003eCervical uterine smear 8\u003c\/p\u003e \u003cp\u003eDiagnostic radioisotope procedures (nuclear medicine) 12\u003c\/p\u003e \u003cp\u003eTransrectal ultrasound (TRUS) prostate biopsy 18\u003c\/p\u003e \u003cp\u003eFlexible cystoscopy 24\u003c\/p\u003e \u003cp\u003eBreast diagnostics 36\u003c\/p\u003e \u003cp\u003eClinical breast examination 38\u003c\/p\u003e \u003cp\u003eCore biopsy 40\u003c\/p\u003e \u003cp\u003eBreast fine-needle aspiration (FNA) 43\u003c\/p\u003e \u003cp\u003eBreast punch biopsy 45\u003c\/p\u003e \u003cp\u003eNipple discharge smear 47\u003c\/p\u003e \u003cp\u003eGenetic testing 48\u003c\/p\u003e \u003cp\u003eWebsites 52\u003c\/p\u003e \u003cp\u003eReferences 52\u003c\/p\u003e \u003cp\u003eProcedure guidelines for Chapter 1\u003c\/p\u003e \u003cp\u003e1.1 Cervical uterine smear using liquid-based cytology 9\u003c\/p\u003e \u003cp\u003e1.2 Unsealed radioactive sources for diagnostic investigations 16\u003c\/p\u003e \u003cp\u003e1.3 Transrectal ultrasound (TRUS) prostate biopsy 21\u003c\/p\u003e \u003cp\u003e1.4 Flexible cystoscopy 27\u003c\/p\u003e \u003cp\u003e1.5 Flexible cystoscopy with stent removal 30\u003c\/p\u003e \u003cp\u003e1.6 Flexible cystoscopy with bladder biopsy 32\u003c\/p\u003e \u003cp\u003e1.7 Flexible cystoscopy with argon plasma coagulation (APC)\/cystodiathermy 35\u003c\/p\u003e \u003cp\u003e1.8 Clinical breast examination 38\u003c\/p\u003e \u003cp\u003e1.9 Core breast biopsy 41\u003c\/p\u003e \u003cp\u003e1.10 Breast fine-needle aspiration (FNA) 43\u003c\/p\u003e \u003cp\u003e1.11 Breast punch biopsy 45\u003c\/p\u003e \u003cp\u003e1.12 Nipple discharge smear 47\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Haematological procedures 57\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eOverview 58\u003c\/p\u003e \u003cp\u003eBone marrow procedures 58\u003c\/p\u003e \u003cp\u003eAspiration and trephine biopsy 58\u003c\/p\u003e \u003cp\u003eBone marrow harvest 67\u003c\/p\u003e \u003cp\u003eApheresis 72\u003c\/p\u003e \u003cp\u003eRibavirin administration 80\u003c\/p\u003e \u003cp\u003ePentamidine isetionate administration 84\u003c\/p\u003e \u003cp\u003eWebsites 87\u003c\/p\u003e \u003cp\u003eReferences 87\u003c\/p\u003e \u003cp\u003eProcedure guidelines for Chapter 2\u003c\/p\u003e \u003cp\u003e2.1 Bone marrow aspiration and trephine biopsy 64\u003c\/p\u003e \u003cp\u003e2.2 Bone marrow harvest 68\u003c\/p\u003e \u003cp\u003e2.3 Apheresis 76\u003c\/p\u003e \u003cp\u003e2.4 Ribavirin administration 82\u003c\/p\u003e \u003cp\u003e2.5 Pentamidine isetionate administration 85\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 Cancer pain assessment and management 91\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eOverview 92\u003c\/p\u003e \u003cp\u003eCancer pain assessment and management 95\u003c\/p\u003e \u003cp\u003ePain management 97\u003c\/p\u003e \u003cp\u003eAcupuncture 104\u003c\/p\u003e \u003cp\u003eInterventional techniques for managing complex cancer-related pain 107\u003c\/p\u003e \u003cp\u003eSingle nerve blocks and injections 108\u003c\/p\u003e \u003cp\u003eRegional peripheral and plexus nerve blocks and infusions 108\u003c\/p\u003e \u003cp\u003eNeuraxial (spinal) blocks: epidural and intrathecal analgesia 109\u003c\/p\u003e \u003cp\u003eEntonox (nitrous oxide) administration 120\u003c\/p\u003e \u003cp\u003eReferences 125\u003c\/p\u003e \u003cp\u003eProcedure guidelines for Chapter 3\u003c\/p\u003e \u003cp\u003e3.1 Acupuncture: preparation and administration 106\u003c\/p\u003e \u003cp\u003e3.2 Epidural\/intrathecal sensory blockade: assessment 114\u003c\/p\u003e \u003cp\u003e3.3 Epidural\/intrathecal exit site dressing change 115\u003c\/p\u003e \u003cp\u003e3.4 Epidural\/intrathecal catheter removal 115\u003c\/p\u003e \u003cp\u003e3.5 Entonox administration 123\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Administration of systemic anticancer therapies 131\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eOverview 132\u003c\/p\u003e \u003cp\u003eSystemic anticancer treatment 132\u003c\/p\u003e \u003cp\u003eSafe handling of hazardous drugs 133\u003c\/p\u003e \u003cp\u003eAdministration of cytotoxic medications by nurses 137\u003c\/p\u003e \u003cp\u003eIntravenous administration of systemic anticancer therapy 138\u003c\/p\u003e \u003cp\u003eExtravasation 142\u003c\/p\u003e \u003cp\u003eOral administration of systemic anticancer therapy 156\u003c\/p\u003e \u003cp\u003eIntramuscular and subcutaneous administration of cytotoxic drugs 162\u003c\/p\u003e \u003cp\u003eTopical application of cytotoxic drugs 164\u003c\/p\u003e \u003cp\u003eIntrathecal administration of cytotoxic drugs 165\u003c\/p\u003e \u003cp\u003eIntrapleural instillation of cytotoxic drugs 168\u003c\/p\u003e \u003cp\u003eIntravesical instillation of cytotoxic drugs 169\u003c\/p\u003e \u003cp\u003eIntraperitoneal instillation of cytotoxic drugs 172\u003c\/p\u003e \u003cp\u003eIntra-arterial administration of cytotoxic drugs 173\u003c\/p\u003e \u003cp\u003eSide-effects of chemotherapy 175\u003c\/p\u003e \u003cp\u003eHaematological side-effects 176\u003c\/p\u003e \u003cp\u003eFatigue 176\u003c\/p\u003e \u003cp\u003eGastrointestinal side-effects 176\u003c\/p\u003e \u003cp\u003eAdverse drug reactions 177\u003c\/p\u003e \u003cp\u003eNeurotoxicity 177\u003c\/p\u003e \u003cp\u003eMucositis\/stomatitis 177\u003c\/p\u003e \u003cp\u003eNephrotoxicity\/haemorrhagic cystitis 178\u003c\/p\u003e \u003cp\u003eCardiotoxicity 178\u003c\/p\u003e \u003cp\u003ePulmonary toxicity 178\u003c\/p\u003e \u003cp\u003eHepatotoxicity 178\u003c\/p\u003e \u003cp\u003eSkin toxicities 178\u003c\/p\u003e \u003cp\u003eAlopecia 178\u003c\/p\u003e \u003cp\u003eClinical research 184\u003c\/p\u003e \u003cp\u003eReferences 193\u003c\/p\u003e \u003cp\u003eProcedure guidelines for Chapter 4\u003c\/p\u003e \u003cp\u003e4.1 Cytotoxic spillage management 135\u003c\/p\u003e \u003cp\u003e4.2 Cytotoxic therapy: intravenous administration of cytotoxic drugs 141\u003c\/p\u003e \u003cp\u003e4.3 Extravasation management: peripheral cannula 150\u003c\/p\u003e \u003cp\u003e4.4 Extravasation: performing flush-out following an extravasation 152\u003c\/p\u003e \u003cp\u003e4.5 Cytotoxic therapy: education for patients on oral cytotoxic drugs 161\u003c\/p\u003e \u003cp\u003e4.6 Cytotoxic therapy: intramuscular administration of cytotoxic drugs (Z-track) 163\u003c\/p\u003e \u003cp\u003e4.7 Cytotoxic therapy: topical application of cytotoxic drugs 164\u003c\/p\u003e \u003cp\u003e4.8 Cytotoxic therapy: intraventricular administration of cytotoxic drugs via an intraventricular access device (Ommaya reservoir) 166\u003c\/p\u003e \u003cp\u003e4.9 Cytotoxic therapy: intrapleural instillation of cytotoxic drugs 168\u003c\/p\u003e \u003cp\u003e4.10 Cytotoxic therapy: intravesical instillation of cytotoxic drugs 170\u003c\/p\u003e \u003cp\u003e4.11 Cytotoxic therapy: intraperitoneal instillation of cytotoxic drugs 172\u003c\/p\u003e \u003cp\u003e4.12 Intra-arterial administration of cytotoxic drugs 174\u003c\/p\u003e \u003cp\u003e4.13 Scalp cooling 182\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Radionuclide therapy 201\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eOverview 202\u003c\/p\u003e \u003cp\u003eRadiation 202\u003c\/p\u003e \u003cp\u003eRadiation protection 202\u003c\/p\u003e \u003cp\u003eUnsealed source therapy 207\u003c\/p\u003e \u003cp\u003eSealed source therapy 211\u003c\/p\u003e \u003cp\u003eSealed source iodine-125 seeds used in prostate malignancies 220\u003c\/p\u003e \u003cp\u003eIntraoral sealed sources 220\u003c\/p\u003e \u003cp\u003eWebsites 223\u003c\/p\u003e \u003cp\u003eReferences 223\u003c\/p\u003e \u003cp\u003eProcedure guidelines for Chapter 5\u003c\/p\u003e \u003cp\u003e5.1 Radiation protection: major spillage of radioactive body fluids through incontinence and\/or vomiting 204\u003c\/p\u003e \u003cp\u003e5.2 Radiation protection: contamination of bare hands by radioactive body fluids 205\u003c\/p\u003e \u003cp\u003e5.3 Radiation protection: death of a patient who has received unsealed radioactive source therapy 205\u003c\/p\u003e \u003cp\u003e5.4 Radiation protection: cardiac arrest of a patient who has received unsealed radioactive source therapy 205\u003c\/p\u003e \u003cp\u003e5.5 Radiation protection: evacuation due to fire of patients who have received unsealed radioactive source therapy 206\u003c\/p\u003e \u003cp\u003e5.6 Unsealed source therapy: entering and leaving the room of a patient who has received an unsealed radioactive source 208\u003c\/p\u003e \u003cp\u003e5.7 Unsealed source therapy: iodine-131 (oral capsule\/liquid): administration 209\u003c\/p\u003e \u003cp\u003e5.8 Unsealed source therapy: iodine-131 mIBG treatment: patient care 209\u003c\/p\u003e \u003cp\u003e5.9 Sealed source therapy: caesium sources (manual or afterloading): patient care 216\u003c\/p\u003e \u003cp\u003e5.10 Sealed source therapy: low dose-rate Selectron treatment 217\u003c\/p\u003e \u003cp\u003e5.11 Sealed source therapy: Selectron applicator removal 218\u003c\/p\u003e \u003cp\u003e5.12 Sealed source therapy: insertion of sealed radioactive sources into the oral cavity 221\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Wound management 227\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eOverview 228\u003c\/p\u003e \u003cp\u003eMalignant fungating wounds 228\u003c\/p\u003e \u003cp\u003eWound assessment 230\u003c\/p\u003e \u003cp\u003eTreatment options 232\u003c\/p\u003e \u003cp\u003ePrinciples of the management of dressings for a malignant fungating wound 235\u003c\/p\u003e \u003cp\u003eLocal wound management 235\u003c\/p\u003e \u003cp\u003eGraft-versus-host disease wounds 244\u003c\/p\u003e \u003cp\u003eDefinition 244\u003c\/p\u003e \u003cp\u003eSkin care following radiotherapy 245\u003c\/p\u003e \u003cp\u003eWebsites and useful addresses 249\u003c\/p\u003e \u003cp\u003eReferences 249\u003c\/p\u003e \u003cp\u003eProcedure guidelines for Chapter 6\u003c\/p\u003e \u003cp\u003e6.1 Assessing a malignant fungating wound 231\u003c\/p\u003e \u003cp\u003e6.2 Dressing a malignant fungating wound 243\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Acute oncology 253\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eOverview 254\u003c\/p\u003e \u003cp\u003eHaematological emergencies 255\u003c\/p\u003e \u003cp\u003eCentral venous access device complications 255\u003c\/p\u003e \u003cp\u003eThrombosis (catheter related) 259\u003c\/p\u003e \u003cp\u003eSepsis 260\u003c\/p\u003e \u003cp\u003eMajor artery rupture 261\u003c\/p\u003e \u003cp\u003eSuperior vena cava obstruction 262\u003c\/p\u003e \u003cp\u003eMetabolic emergencies 264\u003c\/p\u003e \u003cp\u003eHypercalcaemia of malignancy 264\u003c\/p\u003e \u003cp\u003eHypomagnesaemia 267\u003c\/p\u003e \u003cp\u003eSide-effects from chemotherapy agents 268\u003c\/p\u003e \u003cp\u003eDiarrhoea (chemotherapy and radiotherapy induced) 268\u003c\/p\u003e \u003cp\u003eNausea and vomiting 271\u003c\/p\u003e \u003cp\u003eNeutropenic sepsis 277\u003c\/p\u003e \u003cp\u003ePneumonitis 280\u003c\/p\u003e \u003cp\u003eStructural 281\u003c\/p\u003e \u003cp\u003eAscites (malignant) 281\u003c\/p\u003e \u003cp\u003eBowel obstruction (malignant) 287\u003c\/p\u003e \u003cp\u003eMetastatic spinal cord compression 289\u003c\/p\u003e \u003cp\u003ePericardial effusion (malignant) 301\u003c\/p\u003e \u003cp\u003eRaised intracranial pressure due to malignant disease 302\u003c\/p\u003e \u003cp\u003eReferences 303\u003c\/p\u003e \u003cp\u003eProcedure guidelines for Chapter 7\u003c\/p\u003e \u003cp\u003e7.1 Carotid artery rupture (CAR) 262\u003c\/p\u003e \u003cp\u003e7.2 Abdominal paracentesis 284\u003c\/p\u003e \u003cp\u003e7.3 Log rolling for suspected\/confirmed cervical spinal instability 292\u003c\/p\u003e \u003cp\u003e7.4 Positioning for suspected\/confirmed cervical spinal instability: pelvic twist to right 295\u003c\/p\u003e \u003cp\u003e7.5 Log rolling for suspected\/confirmed thoracolumbar spinal instability 297\u003c\/p\u003e \u003cp\u003e7.6 Early mobilization of the patient in bed 298\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Living with and beyond cancer 311\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eOverview 312\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 8.1 Introduction 312\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eThe experience of living with or beyond cancer 312\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 8.2 Welfare advice 315\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eOverview 315\u003c\/p\u003e \u003cp\u003eWebsites 326\u003c\/p\u003e \u003cp\u003eUseful addresses 326\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 8.3 Supporting individuals with sexual concerns as a consequence of cancer 326\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eWomen’s sexual concerns following cancer 329\u003c\/p\u003e \u003cp\u003eInterventions 331\u003c\/p\u003e \u003cp\u003eMen’s sexual concerns following cancer 332\u003c\/p\u003e \u003cp\u003eInterventions 333\u003c\/p\u003e \u003cp\u003eWebsites 334\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 8.4 Nutritional status 334\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eWebsites 339\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 8.5 Compression therapy in the management of lymphoedema 339\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eLymphoedema 339\u003c\/p\u003e \u003cp\u003eAssessment of the patient with lymphoedema and calculation of limb volume 341\u003c\/p\u003e \u003cp\u003eCompression bandaging 348\u003c\/p\u003e \u003cp\u003eCompression garments 357\u003c\/p\u003e \u003cp\u003eAdjustable wrap compression systems 361\u003c\/p\u003e \u003cp\u003eWebsites 365\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 8.6 Non-pharmacological management of breathlessness 366\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eNon-pharmacological support 367\u003c\/p\u003e \u003cp\u003eWebsites 371\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 8.7 Physical activity for people with cancer 371\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eWebsites 377\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 8.8 Cancer-related fatigue and sleep 377\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eCancer-related fatigue 377\u003c\/p\u003e \u003cp\u003eSleep 380\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 8.9 Communication for a patient with a laryngectomy 383\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eWebsites and useful addresses 389\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 8.10 Nipple tattooing 390\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eReferences 396\u003c\/p\u003e \u003cp\u003eProcedure guidelines for Chapter 8\u003c\/p\u003e \u003cp\u003e8.1 Conducting a holistic needs assessment (HNA) 314\u003c\/p\u003e \u003cp\u003e8.1a Developing and actioning a care plan 315\u003c\/p\u003e \u003cp\u003e8.1b Closure and follow-up 315\u003c\/p\u003e \u003cp\u003e8.2 How a patient should make a claim for Personal Independence Payment 322\u003c\/p\u003e \u003cp\u003e8.3 How a patient should make a claim for Attendance Allowance 323\u003c\/p\u003e \u003cp\u003e8.4 How a patient should make a claim for Carer’s Allowance 324\u003c\/p\u003e \u003cp\u003e8.5 How a patient should make a claim for Employment and Support Allowance 325\u003c\/p\u003e \u003cp\u003e8.6 Assessing a patient’s sexual health concerns 327\u003c\/p\u003e \u003cp\u003e8.7 Measuring the weight, height and waist circumference of the patient 336\u003c\/p\u003e \u003cp\u003e8.8 Compression therapy limb volume calculation: lower limb 346\u003c\/p\u003e \u003cp\u003e8.9 Compression therapy limb volume calculation: upper limb 346\u003c\/p\u003e \u003cp\u003e8.10 Compression bandaging (multilayer short-stretch): bandaging arm and the fingers 350\u003c\/p\u003e \u003cp\u003e8.11 Compression bandaging (multilayer short-stretch): bandaging a leg and the toes 354\u003c\/p\u003e \u003cp\u003e8.12 Elastic compression garments: application to the leg 359\u003c\/p\u003e \u003cp\u003e8.13 Elastic compression garments: application to the arm 360\u003c\/p\u003e \u003cp\u003e8.14 Adjustable wrap compression system: application to the lower leg 363\u003c\/p\u003e \u003cp\u003e8.15 Adjustable wrap compression system: application to the arm 364\u003c\/p\u003e \u003cp\u003e8.16 Breathlessness management: using a handheld fan 368\u003c\/p\u003e \u003cp\u003e8.17 Breathlessness management: essential oil administration via aroma stick inhaler 370\u003c\/p\u003e \u003cp\u003e8.18 Supporting physical activity 375\u003c\/p\u003e \u003cp\u003e8.19 Fatigue management 378\u003c\/p\u003e \u003cp\u003e8.20 Relaxation and anxiety management 382\u003c\/p\u003e \u003cp\u003e8.21 HME placement 387\u003c\/p\u003e \u003cp\u003e8.22 Voice prosthesis: cleaning in situ 388\u003c\/p\u003e \u003cp\u003e8.23 Nipple tattooing 394\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 End of life care 403\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eOverview 404\u003c\/p\u003e \u003cp\u003eLast Offices 408\u003c\/p\u003e \u003cp\u003eWebsites and useful addresses 416\u003c\/p\u003e \u003cp\u003eOnline resources 416\u003c\/p\u003e \u003cp\u003eReferences 416\u003c\/p\u003e \u003cp\u003eProcedure guideline for Chapter 9\u003c\/p\u003e \u003cp\u003e9.1 Last Offices 411\u003c\/p\u003e \u003cp\u003eIndex 419\u003c\/p\u003e \u003cp\u003e\u003cb\u003e\u003cb\u003eSara Lister\u003c\/b\u003e \u003c\/b\u003eRN, PGDAE, BSc(Hons), MSC, MBACP, The Pastoral Care Centre, The Royal Marsden NHS Foundation Trust, UK.\u003cb\u003e\u003cbr\u003e\u003cbr\u003eLisa Dougherty\u003c\/b\u003e OBE, RN, MSc, DClinP, Nurse Consultant Intravenous Therapy, The Royal Marsden NHS Foundation Trust, UK.\u003c\/p\u003e \u003cp\u003eAssistant Editor: \u003cb\u003eLouise McNamara, \u003c\/b\u003eB.Nursing; MSc in Advancing Professional Healthcare Practice, UK.\u003c\/p\u003e \u003cp\u003eThe Royal Marsden is the world’s first hospital dedicated to cancer diagnosis, treatment, research and education – a centre of excellence with an international reputation for ground-breaking research and pioneering the very latest in cancer treatments and technologies, as well as specialising in cancer diagnosis and education.  \u003c\/p\u003e \u003cp\u003eThis companion volume to the internationally successful \u003ci\u003eThe Royal Marsden Manual of Clinical Nursing Procedures\u003c\/i\u003e is designed to support practitioners who work specifically with oncology patients by providing detailed evidence-based procedures and rationale, and problem-solving guidance on all aspects of oncology nursing.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eThe Royal Marsden Manual of Cancer Nursing Procedures\u003c\/i\u003e:\u003c\/p\u003e \u003cul\u003e \u003cli\u003eIs organized and structured to represent the needs of the patient along their care pathway\u003c\/li\u003e \u003cli\u003eProvides the latest evidence underpinning all procedures\u003c\/li\u003e \u003cli\u003eIncludes information on haematological procedures; pain assessment and management; wound care; oncological emergencies; and end-of-life care\u003c\/li\u003e \u003cli\u003eGives detailed guidelines on supporting patients living with cancer with practical information on such things as benefits, exercise and nutrition.\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003e\u003ci\u003eThe Royal Marsden Manual of Cancer Nursing Procedures\u003c\/i\u003e is an invaluable, definitive resource for all those involved in the provision of cancer care and support to patients and their families.\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47990333669605,"sku":"NP9781119245186","price":82.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781119245186.jpg?v=1761787397","url":"https:\/\/k12savings.com\/products\/the-royal-marsden-manual-of-cancer-nursing-procedures-isbn-9781119245186","provider":"K12savings","version":"1.0","type":"link"}